No Compromises
Clinical studies have demonstrated that these medications can produce additional weight loss in post-bariatric patients who have experienced weight regain or inadequate initial weight loss
But lawmakers are paying closer attention to virtual prescribing patterns and pill mill models, which could ultimately pave the way for stronger enforcement
Although the reactiveness of NAPQI is high, it is barely harmful at the therapeutic dose because of its abundant glutathione storage and excretion through bile
Because these benefits build over time, and because early postpartum recovery is still a sensitive period, providers may lean toward preserving breastfeeding when a medication is elective or not medically urgent, especially if safety data during lactation is limited
Erak, M., Bellmann-Sickert, K., Els-Heindl, S